MOH — authorised 12 September 2012
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
MOH authorised Aubagio on 12 September 2012
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 12 September 2012.
SANOFI AVENTIS US holds the UAE marketing authorisation.